Haemonetics (HAE) Tops Q2 EPS by 5c ; Offers Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $103.06 +14.17%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $1.12, $0.05 better than the analyst estimate of $1.07. Revenue for the quarter came in at $346 million versus the consensus estimate of $342.58 million.
GUIDANCE:
Haemonetics sees FY2025 EPS of $4.45-$4.75, versus the consensus of $4.59.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA says convenience store sales trail broader retail channels
- Cummins wins battery storage contract for U.S. data center project
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
